7月30日，先声药业盘中下跌5.29%，报12.18港元/股，成交额1402.59万港元。
先声药业所在的制药行业中，板块整体承压，个股中，石药集团跌4.0%，中国生物制药跌5.16%，翰森制药跌2.69%，恒瑞医药跌2.83%，凯莱英跌8.0%。
先声药业集团有限公司是一家从事药品的研发、生产和销售的公司，主要产品包括用于中枢神经系统疾病的必存、用于肿瘤疾病的捷百舒和捷佰立、以及用于自身免疫疾病的英太青等。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.